EUVIMEDEUVIMED entdecken
Crossref

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma

JAMA · 19.05.2026 · 335 (19) · e264329

DOI: 10.1001/jama.2026.4329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, online erschienen am 19.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA, 335(19), e264329. https://doi.org/10.1001/jama.2026.4329

Vancouver

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma. JAMA. 2026;335(19):e264329. doi:10.1001/jama.2026.4329

BibTeX
@article{euvimed2026,
  title = {Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {19},
  pages = {e264329},
  doi = {10.1001/jama.2026.4329}
}
Kostenlos starten →